Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Noncoding mutations drive persistence of a founder preleukemic clone which initiates late relapse in T-ALL.
Blood. 2024 Mar 7;143(10):933-937. doi: 10.1182/blood.2023021906.
Blood. 2024.
PMID: 38194681
Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALL.
Hodder A, Mishra AK, Enshaei A, Baird S, Elbeshlawi I, Bonney D, Clesham K, Cummins M, Vedi A, Gibson B, George L, Ingham D, Jigoulina G, Lancaster D, Lindsay K, Madni M, Malone A, Mitchell B, Moppett J, Motwani J, Moorman AV, Patrick K, Samrin L, Tewari S, Thakur I, O'Connor D, Samarasinghe S, Vora A.
Hodder A, et al. Among authors: jigoulina g.
J Clin Oncol. 2024 Mar 10;42(8):907-914. doi: 10.1200/JCO.23.01392. Epub 2023 Nov 15.
J Clin Oncol. 2024.
PMID: 37967307
Item in Clipboard
SARS CoV-2 Antibody Persistence During Induction Chemotherapy for Pediatric T-Cell Acute Lymphoblastic Leukemia.
Pearce J, Friar S, Jigoulina G, Bate J.
Pearce J, et al. Among authors: jigoulina g.
J Pediatr Hematol Oncol. 2021 Nov 1;43(8):e1258-e1259. doi: 10.1097/MPH.0000000000002182.
J Pediatr Hematol Oncol. 2021.
PMID: 33902067
No abstract available.
Item in Clipboard
Cite
Cite